» Articles » PMID: 33859063

Carbon Monoxide Activates Large-conductance Calcium-activated Potassium Channels of Human Cardiac Fibroblasts Through Various Mechanisms

Overview
Specialty Pharmacology
Date 2021 Apr 16
PMID 33859063
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Carbon monoxide (CO) is a cardioprotectant and potential cardiovascular therapeutic agent. Human cardiac fibroblasts (HCFs) are important determinants of myocardial structure and function. Large-conductance Ca-activated K (BK) channel is a potential therapeutic target for cardiovascular disease. We investigated whether CO modulates BK channels and the signaling pathways in HCFs using whole-cell mode patch-clamp recordings. CO-releasing molecules (CORMs; CORM-2 and CORM-3) significantly increased the amplitudes of BK currents (). The CO-induced stimulating effects on were blocked by pre-treatment with specific nitric oxide synthase (NOS) blockers (L-N-monomethyl arginine citrate and L-N-nitroarginine methyl ester). 8-bromo-cyclic GMP increased . KT5823 (inhibits PKG) or ODQ (inhibits soluble guanylate cyclase) blocked the CO-stimulating effect on . Moreover, 8-bromo-cyclic AMP also increased , and pre-treatment with KT5720 (inhibits PKA) or SQ22536 (inhibits adenylate cyclase) blocked the CO effect. Pre-treatment with Nethylmaleimide (a thiol-alkylating reagent) also blocked the CO effect on , and DLdithiothreitol (a reducing agent) reversed the CO effect. These data suggest that CO activates through NO the NOS and through the PKG, PKA, and -nitrosylation pathways.

Citing Articles

Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response.

Yuan Z, De La Cruz L, Yang X, Wang B Pharmacol Rev. 2022; 74(3):823-873.

PMID: 35738683 PMC: 9553107. DOI: 10.1124/pharmrev.121.000564.


Carbon monoxide signaling and soluble guanylyl cyclase: Facts, myths, and intriguing possibilities.

Lu W, Yang X, Wang B Biochem Pharmacol. 2022; 200:115041.

PMID: 35447132 PMC: 10257856. DOI: 10.1016/j.bcp.2022.115041.


Carbon monoxide activation of delayed rectifier potassium currents of human cardiac fibroblasts through diverse pathways.

Bae H, Kim T, Lim I Korean J Physiol Pharmacol. 2021; 26(1):25-36.

PMID: 34965993 PMC: 8723981. DOI: 10.4196/kjpp.2022.26.1.25.

References
1.
Akamatsu Y, Haga M, Tyagi S, Yamashita K, Graca-Souza A, Ollinger R . Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J. 2004; 18(6):771-2. DOI: 10.1096/fj.03-0921fje. View

2.
Dong D, Zhang Y, Lin D, Chen J, Patschan S, Goligorsky M . Carbon monoxide stimulates the Ca2(+)-activated big conductance k channels in cultured human endothelial cells. Hypertension. 2007; 50(4):643-51. DOI: 10.1161/HYPERTENSIONAHA.107.096057. View

3.
Wilkinson W, Kemp P . The carbon monoxide donor, CORM-2, is an antagonist of ATP-gated, human P2X4 receptors. Purinergic Signal. 2011; 7(1):57-64. PMC: 3083130. DOI: 10.1007/s11302-010-9213-8. View

4.
Lim I, Gibbons S, Lyford G, Miller S, Strege P, Sarr M . Carbon monoxide activates human intestinal smooth muscle L-type Ca2+ channels through a nitric oxide-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2004; 288(1):G7-14. DOI: 10.1152/ajpgi.00205.2004. View

5.
Zhou Y, Lingle C . Paxilline inhibits BK channels by an almost exclusively closed-channel block mechanism. J Gen Physiol. 2014; 144(5):415-40. PMC: 4210426. DOI: 10.1085/jgp.201411259. View